Arktek Passive Vaccine Storage Device
Intellectual Ventures Lab - Global Good Program
The Arktek PSD, a passive storage device, is designed to keep vaccines at appropriate temperatures for a month or more with repeat vaccine retrievals and no need for electricity. It is easily implemented with no need for capitol improvements and has no complex parts to maintain or install. Using a single load of ice blocks for thermal energy storage, the Arktek PSD maintains EPI standard temperatures (0~10°C) for up to 5 liters of vaccines for a minimum 35 days in 43°C day time ambient temperatures. With monthly supplied ice blocks, the Arktek PSD can support vaccination services for a community of approximately 6,000 people. The Arktek PSD is helping to extend vaccination services in remote health posts lacking reliable grid power. This ruggedized vaccine carrier can store up to 300 vaccine doses for over a month. The carrier uses vacuum-insulated technology that allows repeat retrievals and includes a monitor that tracks location using GPS, internal temperature, and the number of retrievals, then transmits this information through USB connection or over SMS messaging.
The Arktek PSD is designed for communities of 6,000 in remote regions of the world lacking grid power especially in GAVI countries. It is currently in use in Ethiopia, Senegal, Nigeria. Interview with representative
Global Good (collaboration between Intellectual Ventures and Bill & Melinda Gates Foundation), AUCMA is moving Arktek into distribution in the communities with the lowest rates of vaccination. Based in China, AUCMA is the country’s largest refrigeration manufacturer.
$2193 USD for more than 100 units. Interview with representative
Solar Fridge. An economic evaluation of these devices in various settings can be found in Vaccine.
Goal 3: to improve and promote good health.
Immunization rates are the lowest in remote, resource-constrained areas where poor infrastructure, unreliable energy, and funding limitations adversely affect safe storage of temperature-sensitive vaccines. These lifesaving vaccines will spoil between manufacture and use if they are not kept at proper temperatures to ensure their viability, potency and efficacy.
Health care practitioners in rural regions and aid workers on vaccination campaigns, etc. especially in GAVI countries.
Manufacturing is in progress with AUCMA, a Chinese refrigeration company
Patented product. Interview with representative
Distributed to healthcare workers directly through large-scale projects with agencies such as the CDC, WHO, and MSF
50 devices currently operating in the field. Over 200 Arkteks are scheduled to be deployed over the next six months. interview with representative
Using a single load of ice blocks for thermal energy storage, the Arktek PSD maintains EPI standard temperatures for up to 5 liters of vaccines for a minimum 35 days in 43°C day time ambient temperatures. Contains 8.6 liters of water ice. Arktek’s tested thermal heat leak is and average of 1 Watt with a day/night cycle of 43°/25°C. Interview with representative
Technical support is provided by the manufacturer, Aucma, or its designated service agents. Interview with representative
The manufacturer, AUCMA, will provide parts in case of any repair needs. Interview with representative
The economic analysis of this device considers initial cost, as well as cost over 10 years, the estimated lifetime of the device.
Stores up to 300 doses
Requires no electricity, holds vaccines at safe temperature for for 30 to 60 days, depending on outside temperatures and humidity with repeat vaccine retrievals, transportable, low-maintenance.
Intellectual Ventures Laboratory, AUCMA, and Global Good. Field trials were conducted in collaboration with the Ministries of Health in Senegal, Nigeria, and Ethiopia. Interview with representative
Mass vaccination is important to control the spread of diseases. However, compromised vaccine efficacy can occur when appropriate actions are not taken to account for temperature changes.
The time in hours without (solar) energy input during which all points in the vaccine compartment remain between +2°C and +10°C without (solar) energy input and at the maximum ambient temperature of the temperature zone for which the appliance is rated.
Normana Bryan A., et al. A passive cold storage device economic model to evaluate selected immunization location scenarios. Elsevier: Vaccine. [Internet] 2013 [cited 2015 June 2]; (31): 5232-5238. Available from: DOI: http://dx.doi.org/10.1016/j.vaccine.2013.08.079
WHO Pre-Qualified under Devices and Equipment category for PQS (Performance, Quality, and Safety). This is a pre-requisite in many countries for a product to be sold and implemented, as it marks that the product has been successfully tested. Field trials were conducted in collaboration with the Ministries of Health in Senegal, Nigeria, and Ethiopia.
World Health Organization’s (WHO) parameters for safe vaccine delivery
In context photographs (0)
You can use the form below to contribute a photo of this product.
In context files & documents (0)
Feedback from users, customers & distributors
Please let us know your experience in using this product through comments below.